Research ArticleBasic Science Investigations
HER2-Positive Tumors Imaged Within 1 Hour Using a Site-Specifically 11C-Labeled Sel-Tagged Affibody Molecule
Helena Wållberg, Jonas Grafström, Qing Cheng, Li Lu, Hanna-Stina Martinsson Ahlzén, Erik Samén, Jan-Olov Thorell, Katarina Johansson, Finn Dunås, Maria Hägg Olofsson, Sharon Stone-Elander, Elias S.J. Arnér and Stefan Ståhl
Journal of Nuclear Medicine September 2012, 53 (9) 1446-1453; DOI: https://doi.org/10.2967/jnumed.111.102194
Helena Wållberg
1Division of Molecular Biotechnology, School of Biotechnology, AlbaNova University Center, Royal Institute of Technology, Stockholm, Sweden
Jonas Grafström
2Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
Qing Cheng
3Division of Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
Li Lu
2Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
4Karoliniska Experimental Research and Imaging Center, Karolinska University Hospital, Solna, Sweden
Hanna-Stina Martinsson Ahlzén
3Division of Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
Erik Samén
2Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
5Department of Neuroradiology, Karolinska University Hospital, Solna, Sweden
Jan-Olov Thorell
2Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
5Department of Neuroradiology, Karolinska University Hospital, Solna, Sweden
Katarina Johansson
3Division of Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
Finn Dunås
6Affibody AB, Solna, Sweden; and
Maria Hägg Olofsson
7Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
Sharon Stone-Elander
2Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
5Department of Neuroradiology, Karolinska University Hospital, Solna, Sweden
Elias S.J. Arnér
3Division of Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
Stefan Ståhl
1Division of Molecular Biotechnology, School of Biotechnology, AlbaNova University Center, Royal Institute of Technology, Stockholm, Sweden
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 53, Issue 9
September 1, 2012
HER2-Positive Tumors Imaged Within 1 Hour Using a Site-Specifically 11C-Labeled Sel-Tagged Affibody Molecule
Helena Wållberg, Jonas Grafström, Qing Cheng, Li Lu, Hanna-Stina Martinsson Ahlzén, Erik Samén, Jan-Olov Thorell, Katarina Johansson, Finn Dunås, Maria Hägg Olofsson, Sharon Stone-Elander, Elias S.J. Arnér, Stefan Ståhl
Journal of Nuclear Medicine Sep 2012, 53 (9) 1446-1453; DOI: 10.2967/jnumed.111.102194
HER2-Positive Tumors Imaged Within 1 Hour Using a Site-Specifically 11C-Labeled Sel-Tagged Affibody Molecule
Helena Wållberg, Jonas Grafström, Qing Cheng, Li Lu, Hanna-Stina Martinsson Ahlzén, Erik Samén, Jan-Olov Thorell, Katarina Johansson, Finn Dunås, Maria Hägg Olofsson, Sharon Stone-Elander, Elias S.J. Arnér, Stefan Ståhl
Journal of Nuclear Medicine Sep 2012, 53 (9) 1446-1453; DOI: 10.2967/jnumed.111.102194